DaVita is down -16.3%, or -$14.87 to $76.41.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on DVA:
- UBS Calls DaVita (NYSE:DVA) Sell-Off “Big Overreaction”
- Dialysis Providers’ Stocks Drop as Novo Nordisk (NYSE:NVO) Halts Ozempic Study
- Dialysis stocks slide after Novo stops kidney outcomes trial early for efficacy
- Warren Buffett and Ken Griffin Have One Thing in Common: They’re Making a Big Bet on These 3 Stocks
- DaVita impact from California wage laws not as bad as feared, says UBS